Arizona Tribune - Boulevard

NYSE - LSE

RYCEF	-2.12%	19.78	$
CMSC	0.16%	21.305	$
RBGPF	-3.31%	68.5	$
RIO	0.45%	102.965	$
GSK	0.71%	50.61	$
RELX	-1.56%	35.87	$
BTI	1.64%	56.495	$
BCE	0.38%	23.68	$
NGG	-0.25%	78.965	$
CMSD	0.02%	21.165	$
BCC	-1.81%	76.4	$
VOD	0.47%	16.115	$
JRI	-0.08%	12.17	$
AZN	-0.14%	161.9	$
BP	2.17%	43.82	$

Featured

Explosives used in sabotage attack on German power lines

Improvised explosive devices were used Tuesday in a sabotage attack near a coal-fired power plant in Germany, with several electricity lines damaged and supply briefly interrupted, officials said.

India's top court drops criminal cases against protesters

India's Supreme Court called off criminal investigations on Tuesday against most of the protesters who took part in demonstrations over the leak of a medical exam paper that forced the resignation of the education minister.

Last news

Exousia Pro Expands its Scientific Advisory Board

Dr. Marvin S. Hausman, MD, will be Chairman of the Scientific Advisory Board.

Aptevo Therapeutics Announces $8 Million Offering Priced At-the-Market Under Nasdaq Rules

SEATTLE, WA / ACCESS Newswire / June 18, 2025 / Aptevo Therapeutics Inc. (Nasdaq:APVO), a clinical-stage biotechnology company focused on developing novel immune-oncology therapeutics based on its proprietary ADAPTIR® and ADAPTIR-FLEX® platform technologies, today announced that it has entered into securities purchase agreements with certain healthcare-focused and institutional investors to purchase (i) 2,465,000 shares of its common stock or pre-funded warrants in lieu thereof and (ii) warrants to purchase up to an aggregate of 12,325,000 shares of its common stock (the "Common Warrants") at a purchase price of $3.25 per share and associated Common Warrants in a registered direct offering priced at-the-market under Nasdaq rules. Each share of common stock is being offered together with five Common Warrants, each to purchase one share of common stock. The Common Warrants will have an exercise price of $3.25 per share, are exercisable upon stockholder approval, and will expire five years following the date of stockholder approval.

Telomir Pharmaceuticals Prevents Cellular Aging in Patient-Derived Cells from Children with Progeria - an Ultra-Rare Genetic Disorder that Causes Rapid Aging

Study used cell lines obtained from the Progeria Research Foundation to evaluate Telomir-1's effects on key drivers of accelerated aging

Avel eCare and Alliant Purchasing Announce Strategic Partnership to Expand Access to Virtual Care Services

SIOUX FALLS, SD / ACCESS Newswire / June 18, 2025 / Avel eCare, a leading provider of telemedicine services, today announced a strategic partnership with Alliant Purchasing, one of the nation's largest independent Group Purchasing Organizations (GPOs), to bring innovative virtual care solutions to more than 35,000 healthcare provider organizations across the U.S.

CS Diagnostics Corp. CSDX to Present at the Small Cap Growth Virtual Investor Conference on June 26, 2025 at 12:30pm EDT

NEUSS, DE / ACCESS Newswire / June 18, 2025 / CS Diagnostics Corp. (OTCQB:CSDX) a global leader in innovative healthcare solutions announced its participation in the Small Cap Growth Virtual Investor Conference hosted by Virtual Investor Conferences (VIC) on Thursday, June 26, 2025. The live, interactive presentation will provide investors with real-time access to company executives with the opportunity to ask questions directly during the webcast. For those unable to attend the live session, a recorded version will be available on demand following the event.

Brenmiller Energy Comments on Reverse Share Split Ahead of Expected Near-Term Milestones

ROSH HA'AYIN, IL / ACCESS Newswire / June 18, 2025 / Brenmiller Energy Ltd. ("Brenmiller", "Brenmiller Energy" or the "Company") (NASDAQ:BNRG), a leading global provider of Thermal Energy Storage ("TES") solutions for industrial and utility customers, today issued a letter from its Chief Executive Officer, Avi Brenmiller.

MIRA Pharmaceuticals' Lead Drug Candidate Ketamir-2 First Manuscript Accepted for Publication in the Peer-Reviewed Journal Frontiers in Pharmacology

MIAMI, FL / ACCESS Newswire / June 18, 2025 / MIRA Pharmaceuticals, Inc (Nasdaq:MIRA) ("MIRA" or the "Company"), a clinical-stage pharmaceutical company developing novel therapeutics for neurologic, neuropsychiatric, and metabolic disorders, today announced that the first manuscript describing its lead drug candidate Ketamir-2, currently being evaluated in an ongoing Phase 1 clinical trial for neuropathic pain, has been accepted for publication in the peer-reviewed journal Frontiers in Pharmacology.

Mipletamig Demonstrates Compelling Clinical Activity in Frontline AML

85% remission rate observed in evaluable frontline AML patientsMipletamig combination enables rare pathway to transplant in a previously ineligible unfit patientNo dose-limiting toxicities observed among evaluable patients; safety profile remains strongEvidence mounts for mipletamig as a potentially transformational addition to standard of care in frontline AML as targeted CD123 x CD3 approach showing power and precision, limited added toxicityMipletamig Trial Momentum Builds as Cohort 3 Nears Full Enrollment at highest dose level evaluated to date in combination therapy

The Battery Show North America Opens Registration for Milestone 15th Anniversary Event

DETROIT, MI / ACCESS Newswire / June 18, 2025 / The Battery Show, North America's largest and most comprehensive event in advanced battery manufacturing and electric vehicles, announces registration is now live. Celebrating its 15th anniversary, the show returns to its dynamic new home, Huntington Place in downtown Detroit, October 6-9, 2025, for four full days of innovation discovery, networking and education shaping the future of battery and EV technology.

Interactive Strength Inc. (Nasdaq:TRNR) Expects to Complete Wattbike Acquisition Imminently After Receiving UK Regulatory Approval

Regulatory Approval by the UK Financial Conduct Authority was Key Requirement for Transaction TimingMinimal Conditions Remain for Deal Completion; Closing Expected in July, 2025

Biodexa Hits Key Milestone For Its Type 1 Diabetes Candidate Tolimidone, Enrolls First Patient In Phase 2a Study

CARDIFF, UNITED KINGDOM / ACCESS Newswire / June 18, 2025 / When it comes to type 1 diabetes, treating this chronic condition can be difficult. After all, with this type of diabetes, the body's immune system attacks and destroys the beta cells that produce insulin. Without the natural ability to produce insulin, glucose from the bloodstream isn't absorbed into cells to provide energy. Since there is no cure, patients with type 1 diabetes need lifelong insulin therapy, typically via injections or a pump. Although type 1 diabetes typically develops in childhood or adolescence, it can happen at any age and is more likely to occur in individuals who are obese or inactive, or both. 1.7 million adults aged 20 or older - or 5.7% of U.S. adults - have the disease and are receiving insulin via shots or a pump.

Organto Foods Announces C$1.0 M Private Placement Financing with a Strategic Investor

TORONTO, ON AND BREDA, THE NETHERLANDS / ACCESS Newswire / June 18, 2025 / Organto Foods Inc. (TSXV:OGO)(OTC PINK:OGOFF) ("Organto" or the "Company") today announced it plans to complete a non-brokered private placement of up to 4,000,000 units of the Company (the "Units") at a price of $0.25 per Unit (the "Private Placement"), with each Unit consisting of one Common Share in the capital of the Company (a "Common Share") and one-half common share purchase warrant of the Company (a "Warrant").

Diamond Care Transportation Expands Non-Emergency Medical Transportation (NEMT) Services Across SC, FL, WA, DC & MD

Safe, Reliable Wheelchair Transportation for Seniors and People with Disabilities - Book Your Ride Today

DEA Bungles Marijuana Policy- Blocks FDA Studies While CCP Illegal Marijuana Grows Flourish

Illegal THC on every corner, Illegal grow ops in plain sight, Yet the DEA continues to block MMJ BioPharma Cultivation's FDA sanctioned application to produce pharmaceutical-grade cannabis pending since 2018.

Argentine ex-president Kirchner to serve prison term at home

A judge on Tuesday agreed to let Argentine ex-president Cristina Kirchner to serve a six-year fraud sentence at home, easing concern among backers keeping a vigil outside her apartment with plans to protest in case she was jailed.

Male victim breaks 'suffocating' silence on Kosovo war rapes

It took 26 years for Ramadan Nishori to talk publicly about his rape -- the first male victim to break the silence about the mass sexual violence during the war in Kosovo.

Pope Leo XIV to revive papal holidays at summer palace

Pope Leo XIV will holiday twice at the papal palace in Castel Gandolfo near Rome this summer, reviving a tradition abandoned by his predecessor Francis, the Vatican said Tuesday.

Indonesia volcano spews colossal ash tower, alert level raised

A volcano in eastern Indonesia spewed a colossal ash tower into the sky on Tuesday, authorities said, after they raised its alert level to the highest of a four-tiered system.

Australian mushroom murder suspect told 'lies upon lies': prosecutor

An Australian woman told "lies upon lies" to cover up her murder of three lunch guests with a toxic mushroom-laced dish, the lead prosecutor said Tuesday.

Diamond Care Transportation Delivers Trusted NEMT Services for Seniors and Disabled Patients Across South Carolina

Need a Ride to Your Medical Appointment? Diamond Care Transportation Offers Safe, On-Time NEMT Services for Seniors and Disabled Patients in South Carolina

Medicure Announces Closing of Purchase Agreement for The Acquisition of West Olympia Pharmacy

WINNIPEG, MB / ACCESS Newswire / June 17, 2025 / Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH)(OTC PINK:MCUJF), a company focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers in the United States market, today announced that further to its news release on April 11, 2025, through its wholly-owned U.S. subsidiary Medicure Pharma Inc., it has closed on the acquisition of 100% of West Olympia Pharmacy Inc. ("West Olympia") from an arms-length third-party (the "Transaction").

New to The Street Signs Backstage ($ BKS) to 12-Part Media Series Covering Music, Sports, and Tokenized Real-World Assets in Entertainment

NEW YORK CITY, NY / ACCESS Newswire / June 17, 2025 / New to The Street, a leading multi-platform media brand for business and financial television, proudly announces the signing of Backstage (NASDAQ:BKS) to an exclusive 12-part national media series.

Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2025 Financial Results

Revenues increased 9% in Q4 2025 compared to Q4 2024, and 12% in FY 2025 compared to FY 2024Net loss improved 27% in Q4 2025 compared to Q4 2024, and 29% in FY 2025 compared to FY 2024EBITDA loss improved 59% in Q4 2025 compared to Q4 2024, and 17% in FY 2025 compared to FY 2024

Applied DNA Announces Retirement of Chairperson and CEO Dr. James A. Hayward

President and COO Judy Murrah Appointed New Chairperson of the Board of Directors and CEO

Labor Smart Inc. Enters Manufacturing Agreement with CKS Distro LLC

JACKSON, WY / ACCESS Newswire / June 17, 2025 / Labor Smart Inc. (OTC PINK:LTNC), a publicly traded brand development and manufacturing company, has entered into a manufacturing agreement with CKS Distro LLC, a company focused on building and distributing consumer packaged goods and lifestyle products.

Water Tower Research Spotlights Ainos' Advances and Milestones in Digital Olfaction and Healthcare: Entering Inflection Point in 2H25

Ainos Hits Inflection Point with AI Nose Pilot Ramp in Senior Care, Robotics, and SemiconductorsKey VELDONA® Human Clinical Studies Secure Taiwan Regulatory Greenlight, Accelerating Development

Visit The New MEMRI Webpage Featuring The Latest Research On The Iran-Israel War

WASHINGTON, DC / ACCESS Newswire / June 17, 2025 / The Middle East Media Research Institute (MEMRI) has launched a new webpage dedicated to covering the Iran-Israel War, including reactions from around the Middle East as well as worldwide.

Industry Leaders and Cutting-Edge Health and Wellness Education Take Center Stage at Newtopia Now 2025

Influential retailers signed on to attend include Albertsons, Home Goods, Instacart, Kroger, Vitamin Shoppe, Walmart, 7-Eleven and many more.

Desert Oasis Healthcare Named "Large Business of the Year" by Greater Coachella Valley Chamber of Commerce

Desert Oasis Healthcare has been named Large Business of the Year by the Greater Coachella Valley Chamber of Commerce, recognizing the organization’s exceptional leadership, innovation, and unwavering commitment to the health and well-being of the communities it serves.

Premiere Orlando 2025 Breaks Records and Redefines the Standard for Professional Beauty Events

ORLANDO, FL / ACCESS Newswire / June 17, 2025 / Premiere Show Group, the nation's leading network of beauty industry events and world-class educational programming, concluded another record-breaking edition of Premiere Orlando this June, setting new benchmarks for education, innovation, and global reach. Held May 31-June 2 at the Orange County Convention Center, attracted 52,000 visits from professionals and students from 47 countries and all 50 U.S. states. Premiere Orlando 2025 marked new heights for the industry by delivering expanded educational opportunities, featuring over 199 new brands, and showcasing the beauty industry's global momentum.

Dolphin Subsidiary 42West Makes Impact at 2025 Tribeca Festival with Exciting Film, TV, and Filmmaker Slate

LOS ANGELES, CA / ACCESS Newswire / June 17, 2025 / The entertainment PR and marketing powerhouse 42West, a subsidiary of Dolphin (NASDAQ:DLPN), celebrated a strong presence at the 2025 Tribeca Festival (June 4-15), representing several feature films, television programs, and filmmakers whose global creativity in cinema and television left their marks across the lineup.

Brenmiller Energy Ltd. Announces Expected Implementation of 5-for-1 Reverse Share Split

ROSH HA'AYIN, IL / ACCESS Newswire / June 17, 2025 / Brenmiller Energy Ltd. ("Brenmiller", "Brenmiller Energy" or the "Company") (Nasdaq:BNRG), a leading global provider of Thermal Energy Storage ("TES") solutions for industrial and utility customers, today announced that a reverse share split of its issued and outstanding ordinary shares, no par value per share (the "Ordinary Shares") at a ratio of 5-for-1 is expected to be implemented after market close on June 18, 2025. The Company's Ordinary Shares will begin trading on the Nasdaq Capital Market on a post-split basis at the market open on June 20, 2025 under the Company's existing trading symbol "BNRG".

Arizona Tribune - Boulevard (English)